Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Nature Chemical Biology|November 1, 2024
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discoveryAlice Dini, Harlan Barker, Emilia Piki, et al.Cellular and Molecular Life Sciences : CMLS|May 3, 2022
New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactomeJuuli Raivola, Alice Dini, Kari Salokas, et al.Molecular Therapy. Oncology|December 5, 2024
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responsesEmilia Piki, Alice Dini, Frida Rantanen, et al.Cell Death & Disease|February 26, 2026
ROR1-PI3K/AKT signaling drives adaptive resistance to cell cycle blockade in TP53 mutated ovarian cancerJuuli Raivola, Frida Rantanen, Alice Dini, et al.Cell Death Discovery|July 3, 2023
ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneityEmilia Piki, Alice Dini, Juuli Raivola, et al.Cell Death & Disease|August 17, 2022
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic interventionJuuli Raivola, Alice Dini, Hanna Karvonen, et al.British Journal of Cancer|December 8, 2022
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinomaAstrid Murumägi, Daniela Ungureanu, Suleiman Khan, et al.Pageof 1